资产负债表(NAYA Biosciences Inc)
截止日期 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
报表类型 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 |
报表年结日 | 1231 | 1231 | 1231 | 1231 | 1231 | 1231 |
原始币种 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 |
上市前/上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 |
流动资产: | ||||||
现金及现金等价物(元) | 942,934.00 | 475,125.00 | 232,424.00 | 1,055,544.00 | 112,485.00 | 2,188,245.00 |
应收账款及票据(元) | 257,210.00 | 176,888.00 | 140,550.00 | 116,781.00 | 74,908.00 | 99,720.00 |
预付款项及其他应收款流动(元) | 945,853.00 | 806,479.00 | 622,294.00 | 365,227.00 | 374,714.00 | 250,878.00 |
存货(元) | 250,066.00 | 266,454.00 | 264,507.00 | 254,220.00 | 280,018.00 | 270,919.00 |
流动资产合计(元) | 2,396,063.00 | 1,724,946.00 | 1,259,775.00 | 1,791,772.00 | 842,125.00 | 2,809,762.00 |
非流动资产: | ||||||
物业、厂房及设备(元) | 441,365.00 | 412,196.00 | 826,418.00 | 772,447.00 | 659,442.00 | 417,642.00 |
无形资产(元) | 3,684,681.00 | 3,889,056.00 | 4,093,431.00 | 1,750,000.00 | - | - |
商誉(元) | 5,878,986.00 | 5,878,986.00 | 5,878,986.00 | 8,224,708.00 | - | - |
长期投资(元) | 3,016,198.00 | 3,043,352.00 | 3,088,248.00 | 1,079,202.00 | 1,132,365.00 | 1,173,577.00 |
非流动资产其他项目(元) | 2,614,466.00 | 3,369,229.00 | 5,740,929.00 | 5,858,042.00 | 4,004,962.00 | 1,750,175.00 |
非流动资产合计(元) | 15,635,696.00 | 16,592,819.00 | 19,628,012.00 | 17,684,399.00 | 5,796,769.00 | 3,341,394.00 |
总资产(元) | 18,031,759.00 | 18,317,765.00 | 20,887,787.00 | 19,476,171.00 | 6,638,894.00 | 6,151,156.00 |
流动负债: | ||||||
融资租赁负债流动(元) | 237,030.00 | 352,575.00 | 397,554.00 | 385,836.00 | 227,026.00 | 234,050.00 |
应付账款及票据(元) | 3,838,185.00 | 4,473,854.00 | 3,840,301.00 | 3,554,357.00 | 2,878,517.00 | 2,948,529.00 |
应付薪酬和福利(元) | 646,838.00 | 766,219.00 | 722,251.00 | 590,598.00 | 1,202,420.00 | 1,220,682.00 |
递延收入流动(元) | 416,745.00 | 513,425.00 | 408,769.00 | 229,921.00 | 161,187.00 | 46,746.00 |
流动负债其他项目(元) | 2,850,000.00 | 2,850,000.00 | 2,850,000.00 | 123,432.00 | - | - |
流动负债合计(元) | 7,988,798.00 | 8,956,073.00 | 8,218,875.00 | 4,884,144.00 | 4,469,150.00 | 4,450,007.00 |
非流动负债: | ||||||
融资租赁负债非流动(元) | 2,506,543.00 | 3,138,004.00 | 5,522,090.00 | 5,622,279.00 | 3,873,289.00 | 1,610,734.00 |
应付账款及票据非流动(元) | 1,172,902.00 | 1,213,533.00 | 1,253,997.00 | 1,095,000.00 | - | - |
递延所得税负债非流动(元) | - | - | - | 1,949.00 | 1,949.00 | 1,949.00 |
非流动负债其他项目(元) | 5,000,000.00 | 5,000,000.00 | 5,000,000.00 | 7,500,000.00 | - | - |
非流动负债合计(元) | 8,679,445.00 | 9,351,537.00 | 11,776,087.00 | 14,219,228.00 | 3,875,238.00 | 1,612,683.00 |
总负债(元) | 16,668,243.00 | 18,307,610.00 | 19,994,962.00 | 19,103,372.00 | 8,344,388.00 | 6,062,690.00 |
股东权益: | ||||||
普通股(元) | 386.00 | 262.00 | 249.00 | 247.00 | 83.00 | 1,397.00 |
优先股(元) | 7,506,404.00 | 6,500,000.00 | 6,000,000.00 | - | - | - |
股本溢价(元) | 55,767,189.00 | 52,924,551.00 | 52,710,721.00 | 56,195,915.00 | 52,869,346.00 | 52,421,481.00 |
留存收益(元) | -61,910,463.00 | -59,414,658.00 | -57,818,145.00 | -55,823,363.00 | -54,574,923.00 | -52,334,412.00 |
归属于母公司股东权益(元) | 1,363,516.00 | 10,155.00 | 892,825.00 | 372,799.00 | -1,705,494.00 | 88,466.00 |
股东权益合计(元) | 1,363,516.00 | 10,155.00 | 892,825.00 | 372,799.00 | -1,705,494.00 | 88,466.00 |
负债及股东权益合计(元) | 18,031,759.00 | 18,317,765.00 | 20,887,787.00 | 19,476,171.00 | 6,638,894.00 | 6,151,156.00 |
公告日期 | 2024-08-14 | 2024-05-15 | 2024-04-16 | 2023-11-13 | 2023-08-14 | 2023-05-15 |
会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 |
审计意见 | ||||||
核数师 |
截止日期 |
报表类型 |
报表年结日 |
原始币种 |
上市前/上市后 |
流动资产: |
现金及现金等价物(元) |
应收账款及票据(元) |
预付款项及其他应收款流动(元) |
存货(元) |
流动资产合计(元) |
非流动资产: |
物业、厂房及设备(元) |
无形资产(元) |
商誉(元) |
长期投资(元) |
非流动资产其他项目(元) |
非流动资产合计(元) |
总资产(元) |
流动负债: |
融资租赁负债流动(元) |
应付账款及票据(元) |
应付薪酬和福利(元) |
递延收入流动(元) |
流动负债其他项目(元) |
流动负债合计(元) |
非流动负债: |
融资租赁负债非流动(元) |
应付账款及票据非流动(元) |
递延所得税负债非流动(元) |
非流动负债其他项目(元) |
非流动负债合计(元) |
总负债(元) |
股东权益: |
普通股(元) |
优先股(元) |
股本溢价(元) |
留存收益(元) |
归属于母公司股东权益(元) |
股东权益合计(元) |
负债及股东权益合计(元) |
公告日期 |
会计准则 |
审计意见 |
核数师 |
Showing 1 to 45 of 45 entries